Honoring Lyme Disease Awareness Month with a Multi-Year Plan to Change the Lyme Disease Status Quo
By: Daniel Desautels PhD, Health Scientist, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Deanna Lebel MHS, ORISE Fellow, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services and Kristen Honey PhD, PMP, Chief Data Scientist, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services
Summary:
HHS addressing serious national threats of Lyme disease and other tickborne illnesses
The Multi-Year Plan includes five years of HHS Lyme Innovation goals, impacts to date, and future activities to move the needle on Lyme disease and tickborne diseases with Lyme disease patients at the core of the HHS innovation process. Launched in 2018, the HHS Lyme Innovation initiative harnesses the power of collaboration, data-driven innovation, and emerging technologies to address the serious threats of Lyme disease and other tickborne illnesses.
Lyme disease is the most common vector-borne disease in the United States with approximately 63,000 cases reported to the Centers for Disease Control and Prevention in 2022. But reported cases tell only a portion of the story: CDC estimates approximately 476,000 people are diagnosed with Lyme disease in the United States each year. Due to shifting land use patterns, global travel and trade, and a changing climate, the threat of existing and emerging tickborne diseases continues to grow.
“The HHS Lyme Innovation initiative has made groundbreaking progress accelerating patient-informed innovations for diagnostics, treatment, and care,” said Acting Deputy Assistant Secretary for Science and Medicine, Leith J. States, MD, MPH, MBA, FACPM. As described in the Multi-Year Plan, HHS Lyme Innovation is a broad umbrella of methods with innovation and partnership activities.
On-going efforts will continue advancing Lyme disease diagnostics, open data for Lyme Innovation, human-centered design for Lyme Innovation, and scientific understanding of Lyme infection-associated chronic illnesses .
The Multi-Year Plan aligns with the National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People – PDF (Vector-Borne Disease National Strategy), published earlier this year. The first interagency effort of its kind, the Vector-Borne Disease National Strategy identifies and describes federal priorities to detect, prevent, respond to, and control diseases and conditions caused by vectors in the United States.
HHS and CDC are leading execution of the strategy in consultation with agencies across the federal government. Successful implementation of the Vector-Borne Disease National Strategy depends on strong collaboration within the government and with external partners. On May 23, 2024, HHS will present updates on the Vector-Borne Disease National Strategy via livestream at https://www.hhs.gov/live/index.html.
Moving the needle on Lyme disease will require continued collaboration, support, leadership, and excellence in innovation and implementation. Collaboration within and outside of the federal government is necessary to protect the nation and save lives. Government transparency is a priority for the HHS Lyme Innovation Initiative, which rests on a foundation of open science, open data, and open innovation.
______________
**Comment**
Don’t expect anything helpful to come out of this. A lot of money will be appropriated, the same crappy science will be done, and the same pockets will be lined.
In a recent meta-analysis1,2 posted on preprints.org, Japanese researchers warn of potentially deadly risks to patients who receive blood from people who have taken mRNA covid injections and call for urgent action to ensure the safety of the global blood supply. According to the authors:3
… many countries around the world have reported that so-called genetic vaccines, such as those using modified mRNA encoding the spike protein and lipid nanoparticles as the drug delivery system, have resulted in post-vaccination thrombosis and subsequent cardiovascular damage, as well as a wide variety of diseases involving all organs and systems, including the nervous system …
[B]ased on these circumstances and the volume of evidence that has recently come to light, we call the attention of medical professionals to the various risks associated with blood transfusions using blood products derived from people who have suffered from long covid and from genetic vaccine recipients, including those who have received mRNA vaccines, and we make proposals regarding specific tests, testing methods, and regulations to deal with these risks.
Blood From Injected Donors May Pose Risk to Neurological Health
One particular risk addressed in this paper is the implications of blood tainted with prion-like structures found within the spike protein. Prions are misfolded proteins that can cause neurodegenerative diseases, such as Creutzfeldt-Jakob Disease (“CJD”) in humans, by inducing the misfolding of normal proteins in the brain.
Prion diseases are characterised by a long incubation period, followed by rapid progression and high mortality. The suggestion that the spike protein of SARS-CoV-2, especially from certain variants, might contain prion-like domains raises concerns for several reasons:
Transmission risk – If spike proteins with prion-like structures can be transmitted through blood transfusions, there might be a risk of inducing prion diseases in recipients. Prion diseases are notoriously difficult to diagnose early, have no cure and are fatal, making any potential transmission through blood products a significant safety concern.
Detection and removal challenges – Current blood screening processes do not specifically test for prions, partly because prion diseases are rare and partly due to the technical challenges in detecting prions at low concentrations. If spike proteins with prion-like properties are present in the blood of covid injected people, existing blood safety protocols may not be adequate to prevent transmission.
Long-term safety concerns – Prion diseases have long latency periods, meaning that symptoms can appear years or even decades after exposure. This delay complicates efforts to trace the source of an infection back to a blood transfusion and assess the safety of blood supplies over time.
Impacts on blood supply management – Concerns about the potential risks associated with prion-like structures in spike proteins might lead to changes in donor eligibility criteria or the implementation of additional screening measures. These changes could impact the availability of blood products, which are critical for routine medical procedures.
Public confidence – Public awareness of these potential risks, even if they are theoretical or have a very low likelihood of occurring, could affect people’s willingness to donate or receive blood transfusions, thereby lowering blood donation rates and the overall trust in the safety of blood transfusions.
The authors stress the need for comprehensive studies to better understand the implications of these prion-like structures in the spike protein, not only for mRNA jab safety but also for the broader implications for public health measures like blood transfusion practices.
Other Potential Health Hazards of Contaminated Blood
Contaminated blood may also pose other serious health risks, including:
1. Reduced immune function among blood recipients – It’s been shown that the more doses of the covid “vaccine” you’ve received, the more likely you are to suffer future infections, either by SARS-CoV-2 or other viruses, due to antibody-dependent enhancement.
Blood donations from people who have received several doses of mRNA injections may not provide adequate immunity against common infections, resulting in subclinical infections and diseases in recipients.
2. Formation of blood clots and amyloid aggregates – If the immune system of a blood recipient isn’t strong enough to neutralise spike protein, blood clots and amyloid aggregates may also form.
3. Chronic inflammation – Prolonged exposure to the antigens from the covid-19 injections can trigger the generation of IgG4 antibodies, resulting in chronic inflammation and immune dysfunction.
IgG4 antibodies are often associated with chronic exposure to antigens, such as those seen in persistent infections, certain cancers, and prolonged exposure to allergens. IgG4 antibodies are also associated with a unique condition known as IgG4-Related Disease (IgG4-RD), a fibro-inflammatory condition characterised by swellings or masses in affected organs.4
Blood Transfusions and the Risk of Autoimmune Diseases
The authors also raise concerns about the potential of contaminated blood to cause autoimmune diseases in recipients. Recent research found that the RNA pseudouridylation, a process in which uracil is swapped out for synthetic methylpseudouridine, can cause frameshifting, basically a glitch in the decoding, which can trigger the production of off-target aberrant proteins.
The antibodies that develop as a result may, in turn, trigger off-target immune reactions. In addition to that, lipid nanoparticles (“LNPs”), a key component of the covid injections, have been identified as highly inflammatory and possessing more potent adjuvant activity compared to traditional vaccine adjuvants, which further increases the risk of an autoimmune response. As reported in the featured paper:5
Recent studies have shown that RNA pseudouridylation can result in frameshifting. It is not yet clear whether a portion of the pseudouridinated mRNA for the spike protein is translated into another protein of unknown function in vaccine recipients. If these proteins are also pathogenic, additional testing for such frameshift proteins may be needed in the future.
Even if a frameshift protein is not toxic, it must be foreign to the body and could cause autoimmune disease. In addition, LNPs themselves are highly inflammatory substances … LNPs have been found to have stronger adjuvant activity than the adjuvants used in conventional vaccines, and there is also concern about autoimmune diseases resulting from this aspect.
Thus, although it is not clear what the causative agent of autoimmune disease is, the large number of reported cases of autoimmune disease following genetic vaccination is extremely concerning.
The very mechanism of gene vaccines that causes one’s own cells to produce the antigens of pathogens carries the risk of inducing autoimmune diseases, which cannot be completely avoided even if mRNA pseudouridylation technology is used.
In this context, individuals with a positive blood test for spike protein may need to have interviews and additional tests for autoimmune disease indicators, such as antinuclear antibodies.
Alternatively, if the amino acid sequence of the protein resulting from the frameshift is predictable, these candidate proteins could be included in the initial mass spectrometry assay. In any case, it is particularly important to develop tests and establish medical care settings in anticipation of these situations.
Proposals for Managing Blood Collection
The authors outline several specific proposals for managing blood collection and blood products from individuals who have received genetic “vaccines.” Given the variety of blood-related abnormalities observed post-injection, the researchers argue that rigorous and precautionary measures in blood handling and transfusion practices have now become a necessity.
A key part of the proposal involves conducting thorough interviews with potential blood donors. These interviews should cover their vaccination status, number of doses received, their covid-19 infection history, and any symptoms they might be experiencing that could indicate conditions like post-vaccination syndrome (“PVS”), long covid or other complications.
The researchers also recommend deferral periods for blood collected from covid injection recipients – 48 hours for mRNA shots and six weeks for AstraZeneca DNA jab recipients. A series of tests are also proposed to ensure the safety of collected blood, including:
Mass spectrometry to measure spike protein content
PCR for detecting the presence of spike protein mRNA and DNA
Testing for markers associated with autoimmune disorders
Enzyme-linked immunosorbent assay (ELISA)
Immunophenotyping
Liquid biopsies combined with proteomics to detect and quantify spike protein and its mRNA
The authors also note that policies and procedures must be constantly revised as new risks and problems with blood products derived from mRNA and DNA injection recipients are identified.
Ensuring Safety of Current Blood Products
The paper also reviews strategies to ensure the safety of blood products already collected, highlighting the complex challenges that medical institutions, regulatory bodies, and the broader healthcare ecosystem must navigate in the wake of the widespread use of mRNA injections.
The primary concern is the risk posed to patients by the use of blood products from donors who have received gene-based injections without confirming the presence or absence of spike proteins or modified mRNA. To ensure their safety, methods to quantify potential contaminants must be developed and implemented as soon as possible.
Another critical issue that must be addressed is the current lack of reliable methods to remove spike proteins or modified mRNA from blood products. The authors warn that, given the potential persistence, low solubility, heat resistance and radiation resistance of these components, current methodologies are inadequate for the job. The only solution, they say, is to discard all blood products found to contain these contaminants until effective removal techniques are established.
Researchers Call for Widespread Blood Testing
Additionally, the researchers call for widespread testing of both injected and non-injected to assess the potential transmission of spike proteins through exosomes (so-called shedding).
As noted by the authors:
… when exosomes collected from vaccine recipients were administered to mice that had not been vaccinated with the genetic vaccine, the spike protein was transmitted.
Therefore, it cannot be denied that the spike protein and its modified genes can be transmitted through exosomes. For this reason, we suggest that full testing be done initially, regardless of genetic vaccination status, and that a cohort study be conducted to quickly capture the full picture …
In addition … it cannot be ruled out that even those who have not been vaccinated with the genetic vaccine, but have had long covid, may have residual spike proteins or fibrin-derived microthrombi in their bodies, so it would be advisable to conduct the same testing and follow-up as for genetic vaccine recipients.
The presence or absence and amount of anti-nucleocapsid antibodies as well as antibody isotypes may be an indicator(s) in distinguishing whether genetic vaccination or long covid is the cause. In any case, these cohort studies are expected to help establish cutoff values for blood levels of spike protein and other substances to determine the safety of blood products.
Faksova et al. conducted a large cohort study of 99 million people using a multinational Global Vaccine Data NetworkTM (GVDN®) and found a significantly increased risk of myocarditis, pericarditis, Guillain-Barre syndrome and cerebral venous sinus thrombosis in genetic vaccine recipients.
Ensuring the traceability of blood products and establishing a rigorous legal and regulatory framework to manage the myriad issues arising from the use of blood products derived from covid-injected individuals are also paramount. This includes creating systems for the registration of all potential donors, ensuring the traceability of blood products and conducting recipient outcome studies.
Call to Pause: Evaluating the Risks and Benefits of Genetic Vaccines for a Safer Future
In conclusion, the authors point out that if we continue using mRNA-LPN-based platforms to replace conventional vaccines or create new ones, then the risks to our blood and bone marrow supply will be augmented further.
“The impact of these genetic vaccines on blood products and the actual damage caused by them are unknown at present,” they write.6
Therefore, in order to avoid these risks and prevent further expansion of blood contamination and complication of the situation, we strongly request that the vaccination campaign using genetic vaccines be suspendedand that a harm-benefit assessment be carried out as early as possible, as called for by Fraiman et al.7 and Polykretis et al.8
T]he health injuries caused by genetic vaccination are already extremely serious, and it is high time that countries and relevant organisations take concrete steps together to identify the risks and to control and resolve them.
Dr. Joseph Mercola is the founder and owner of Mercola.com, a Board-Certified Family Medicine Osteopathic Physician, a Fellow of the American College of Nutrition and a New York Times bestselling author. He publishes multiple articles a day covering a wide range of topics on his website Mercola.com.
_______________
Japan Ahead of the Curve
Japan appears to be ahead of the curve not only in showing the seriousness of the mRNA injection issues, but politically as well. Recently, Kazuhiro Haraguichi, former Japanese Minister for Internal Affairs has become the first major politician to apologize to the unvaccinated for the tsunami of deaths occurring among the ‘vaccinated.’ After getting two out of three COVID shots which were from ‘lethal’ batches, he developed a rapidly progressing form of cancer. Three of his colleagues were also severely affected, but they haven’t spoken out. He states those that do are censored. He has urged people to stand united in challenging the government.
Thelibertybeacon.com reports: One of the key points in Haraguchi’s speech was his criticism of the ban on Ivermectin, a drug developed by Dr. Satoshi Omura, which he believed could have played a significant role in combating the pandemic. Haraguchi questioned the motives behind the ban, suggesting that economic interests were prioritized over public health.
In this video, James Roguski explains that while the ‘Pandemic Treaty’ as such did not pass, Amendments to the IHR have been adopted and will be legally binding in 12 months unless countries refuse them. He also explains the more subtly devious root issue that those in the WHO are convinced that the only answers to ‘pandemics’ are testing, pharmaceutical drugs, and ‘vaccines.’ More clearly, the WHO has the misguided belief that a diagnostic test can determine if a person is a danger to another person. The COVID shots have proven to be a catastrophe, as well as many of the drugs they used for COVID.
Just as deviously subtle, the IHR wording states that a communicable disease, in order to be considered a ‘pandemic’ is one that causes or is at risk of causing:
wide geographical spread
a capacity problem in health care systems
substantial social and or economic disruption – yet they blame the disease rather than the government’s response (lockdowns, firing unvaccinated people, etc).
whole of government or whole of society approaches
Another glaring problem is the amendments offer no concrete markers that offer actual proof such as hospital data or mortality to define in solid terms a true ‘pandemic’ vs a declaration.
In their definition of ‘equity,’ they want to transfer wealth (steal money from wealthier nations, funnel it through WHO to build out big pharma to have geographically distributed manufacturing of medical products such as gene therapies, vaccines and drugs, but not vitamins, clean water and nutritious food, etc.). There is a blind and total acceptance of Big Pharma’s products despite the historical reality showing the damage and death they can cause.
Roguski also states that we already lost our sovereignty to Big Pharma which pays the FDA to approve their products that kill people. WHO simply brokered the deal called the International Health Regulation (IHR) amendments, so they can manage the insanity.
“This is a very skillfully crafted scam.” ~ James Roguski
The 77th World Health Assembly HAS adopted a substantial package of amendments to the International Health Regulations. We the People have suffered a stunning defeat. The battle continues.
The recently adopted amendments will facilitate an enormous global build up of the Pharmaceutical Hospital Emergency Industrial Complex which seeks to trigger ongoing “pandemic emergencies” that will be made even worse by “relevant health products.”
Article 1
“relevant health products” means those health products needed to respond to public health emergencies of international concern, including pandemic emergencies, which may include medicines, vaccines, diagnostics, medical devices, vector control products, personal protective equipment, decontamination products, assistive products, antidotes, cell- and gene-based therapies, and other health technologies.
(See link for article)
Important excerpt:
For those who believe that the adoption of these amendments is somehow a “victory” for health freedom or that the amendments that were adopted “aren’t that bad” or that they “could have been worse,” or that we “dodged a number of bullets,” please realize that over the past year, quite a lot of misinformation has been spread regarding these amendments.
The build-up of the Pharmaceutical Hospital Emergency Industrial Complex that these amendments seek to implement in support of the equitable distribution of “relevant medical products” is certainly NOT a “victory” that should be celebrated.
Stop allowing yourself to be deceived.
________________
**Comment**
This is why I didn’t celebrate too early. I had a feeling something like this would go down.
This is proof positive this organization needs to go. Period.
In yet another example of rats jumping ship, former White House Coronavirus Coordinator Dr. Deborah Birx admits some obvious truths while couching them in lies.
It’s important to remember that Birx and former CDC director Robert Redfield, both Army medical officers, knowingly falsified scientific data published in the New England Journal of Medicinefraudulently claiming that an HIV vaccine they helped develop was effective.They knew the vaccine was worthless, and Redfield confessed that his analyses were faulty and deceptive, but instead of being held accountable, Congress appropriated $20 million to the military to support Redfield and Birx’s research project. Public Citizen complained in a 1994 letter that the money caused the Army to kill the investigation and “whitewash” Redfield’s crimes.
The fraud propelled Birx and Redfield into stellar careers as health officials.
Birx, a life-long protégé to both Redfield and Anthony Fauci, served on the board of Bill Gates’Global Fund. Redfield, Birx and Fauci, who were interconnected for the HIV debacle, also conveniently led the White House coronavirus task force together.
Dr. Deborah Birx Drops Massive COVID ‘Vaccine’ Confession (While Still Pushing Lie)
“Scarf Lady” Dr. Deborah Birx Drops Massive Truth Bomb
First, Birx admitted that she “knew” the COVID shots “were not going to protect against infection.”
Whether she knew or not, millions taking them didn’t, and authorities sure didn’t tell them.
The shots weren’t even tested for reduction in hospitalization, death, or transmission, rather they were tested for reduction in severe symptoms – which is not the proper endpoint for “vaccine” efficacy.
The shocking confession came during an interview with former CNN anchor, COVID shot injured, and ivermectin user Chris Cuomo, who recently said, “Joe Rogan was right” about “horse dewormer,” which he once shamed people for taking.
But while Birx is revealing some truth, she’s still pushing a big lie. Watch her tiptoe between truth and fiction and listen to the HIV/AIDS mismanagement history as well as the lie that the COVID shots were ‘very effective for what they were supposed to be used for, which was prevent severe disease, and hospitalization, and death.’
Induction of antibodies cannot prevent infection by an agent such as SARS-CoV-2 that invades through the respiratory tract. Moreover, none of the vaccine trials have provided any evidence that ‘vaccination’ prevents transmission of the infection by vaccinated individuals; urging vaccination to “protect others” therefore has no basis in fact.
The Dangerous Dames Courtenay Turner & Dr Lee Merritt are joined by dangerous dude Adam Finnegan.
Adam is the author of “The Sleeper Agent”. He shares his personal medical journey that led him down the path of rigorous research and discovery. The conversation spans subjects of Lyme disease, history of bioweapons, the question of virology and what really makes us humans ill.
According to Finnegan, Lyme disease was not invented at the Plum Island lab in 1975, it was weaponized long before, around 1939 in Germany where Eric Traub conducted tests there with his weaponized strains. The actual spirochete, before it was weaponized, had been around for many years, and was a bird strain of Borrelia called Borrelia anserina,[2] and had several developments, but may have been weaponized once more during Traub’s return to the United States after WWII and conducted tests with it on Plum Island.
Regarding the findings in the five thousand year old mummy, scientists did NOT find Bb, or Ba, nor Bg – the three species of borrelia responsible for Lyme disease. They simply found traces of what they thought might be borrelia species but said further testing is needed to confirm this.
Madison Area Lyme Support Group 